DL
Therapeutic Areas
Chipscreen Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Chidamide (Tucidinostat) | Lymphoma (and other cancers) | Approved/Marketed |
| CS08399 | MTAP-Deficient Tumors | IND Approved |
| Second Marketed Product | Not specified on homepage | Approved/Marketed |